Cargando…

Depression in Children and Adolescents with Autism Spectrum Disorder

Autism spectrum disorder (ASD) has a high rate of psychiatric comorbidity. The prevalence of comorbid depression seems to correlate with higher functioning forms of ASD and increasing age. Adolescence is a time when youth struggle with identity and interpersonal relationships, and a diagnosis of ASD...

Descripción completa

Detalles Bibliográficos
Autor principal: DeFilippis, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162511/
https://www.ncbi.nlm.nih.gov/pubmed/30134542
http://dx.doi.org/10.3390/children5090112
_version_ 1783359163771912192
author DeFilippis, Melissa
author_facet DeFilippis, Melissa
author_sort DeFilippis, Melissa
collection PubMed
description Autism spectrum disorder (ASD) has a high rate of psychiatric comorbidity. The prevalence of comorbid depression seems to correlate with higher functioning forms of ASD and increasing age. Adolescence is a time when youth struggle with identity and interpersonal relationships, and a diagnosis of ASD further complicates this process. Adolescents with ASD may be more aware of the social communication deficits that come with the diagnosis than children with ASD, and it is theorized that higher functioning adolescents may experience this more acutely. While this may be true, the lack of reliable rating and diagnostic scales for depression in individuals with ASD makes it difficult to accurately measure rates of depression among individuals with more severe verbal deficits. While some research has focused on the prevalence of comorbid depression in children and adolescents with ASD and on the associated risk factors, there is very little evidence guiding treatment, including no empirical studies on psychopharmacology for depression in this population. Available evidence exists only in psychosocial approaches to treatment at this time and is mostly limited to adult studies. Current evidence will be presented in this review, including prevalence rates of depression in youth with ASD, various risk and protective factors, the use of diagnostic rating scales, and treatment studies. The lack of evidence supporting various treatment approaches will be highlighted, including challenges specific to the treatment of depression in ASD, which are not addressed in the current treatment studies in typically developing youth with depression.
format Online
Article
Text
id pubmed-6162511
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61625112018-10-16 Depression in Children and Adolescents with Autism Spectrum Disorder DeFilippis, Melissa Children (Basel) Review Autism spectrum disorder (ASD) has a high rate of psychiatric comorbidity. The prevalence of comorbid depression seems to correlate with higher functioning forms of ASD and increasing age. Adolescence is a time when youth struggle with identity and interpersonal relationships, and a diagnosis of ASD further complicates this process. Adolescents with ASD may be more aware of the social communication deficits that come with the diagnosis than children with ASD, and it is theorized that higher functioning adolescents may experience this more acutely. While this may be true, the lack of reliable rating and diagnostic scales for depression in individuals with ASD makes it difficult to accurately measure rates of depression among individuals with more severe verbal deficits. While some research has focused on the prevalence of comorbid depression in children and adolescents with ASD and on the associated risk factors, there is very little evidence guiding treatment, including no empirical studies on psychopharmacology for depression in this population. Available evidence exists only in psychosocial approaches to treatment at this time and is mostly limited to adult studies. Current evidence will be presented in this review, including prevalence rates of depression in youth with ASD, various risk and protective factors, the use of diagnostic rating scales, and treatment studies. The lack of evidence supporting various treatment approaches will be highlighted, including challenges specific to the treatment of depression in ASD, which are not addressed in the current treatment studies in typically developing youth with depression. MDPI 2018-08-21 /pmc/articles/PMC6162511/ /pubmed/30134542 http://dx.doi.org/10.3390/children5090112 Text en © 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
DeFilippis, Melissa
Depression in Children and Adolescents with Autism Spectrum Disorder
title Depression in Children and Adolescents with Autism Spectrum Disorder
title_full Depression in Children and Adolescents with Autism Spectrum Disorder
title_fullStr Depression in Children and Adolescents with Autism Spectrum Disorder
title_full_unstemmed Depression in Children and Adolescents with Autism Spectrum Disorder
title_short Depression in Children and Adolescents with Autism Spectrum Disorder
title_sort depression in children and adolescents with autism spectrum disorder
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162511/
https://www.ncbi.nlm.nih.gov/pubmed/30134542
http://dx.doi.org/10.3390/children5090112
work_keys_str_mv AT defilippismelissa depressioninchildrenandadolescentswithautismspectrumdisorder